Atara Biotherapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATRA and other ETFs, options, and stocks.

About ATRA

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need.

CEO

Pascal Touchon

CEOPascal Touchon

Employees

225

Employees225

Headquarters

Thousand Oaks, California

HeadquartersThousand Oaks, California

Founded

2012

Founded2012

Employees

225

Employees225

ATRA Key Statistics

Market cap

68.45M

Market cap68.45M

Price-Earnings ratio

-0.23

Price-Earnings ratio-0.23

Dividend yield

—

Dividend yield—

Average volume

1.07M

Average volume1.07M

High today

$0.6399

High today$0.6399

Low today

$0.5593

Low today$0.5593

Open price

$0.5977

Open price$0.5977

Volume

1.44M

Volume1.44M

52 Week high

$3.02

52 Week high$3.02

52 Week low

$0.1986

52 Week low$0.1986

ATRA News

Yahoo Finance 3d

Stoke Therapeutics, Inc. Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

Stoke Therapeutics, Inc. (STOK) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.60. This compares to loss...

Yahoo Finance 5d

Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c) - Yahoo Finance

THOUSAND OAKS, Calif., May 03, 2024--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogen...